Treatment of lung cells with histone deacetylase inhibitors

Details Treatment of lung cells with histone deacetylase inhibitors Treatment of lung cells with histone deacetylase inhibitors

2003-11-19

2008-01-01

Zucker, Paul A. (Department: 1621)

Organic compounds -- part of the class 532-570 series

Organic compounds

Hydroxamate esters or chalcogen analogues thereof

C514S575000

Reexamination Certificate

active

07314953

ABSTRACT:
Lung disease, such as cystic fibrosis (CF), chronic obstructive pulmonary disease (COPD), asthma or acute and chronic bronchitis, can be treated with an oxyamide-containing compound.

REFERENCES:
patent: 2680755 (1954-06-01), Robeson et al.
patent: 2840586 (1958-06-01), Inhoffen
patent: 3479396 (1969-11-01), Buu-Hoi et la.
patent: 3551574 (1970-12-01), Frohberger et al.
patent: 3624127 (1971-11-01), Shaw et al.
patent: 3674884 (1972-07-01), Moritani et al.
patent: 3687955 (1972-08-01), Cerbati et al.
patent: 3755604 (1973-08-01), Gallo
patent: 3781314 (1973-12-01), Bollag et al.
patent: 3886278 (1975-05-01), Gallo
patent: 3909353 (1975-09-01), Tsuchida et al.
patent: 3978100 (1976-08-01), Fujita et al.
patent: 3984440 (1976-10-01), Bollag et al.
patent: 4011339 (1977-03-01), Galantay et al.
patent: 4024182 (1977-05-01), Kathawala
patent: 4044149 (1977-08-01), Fields et al.
patent: 4048332 (1977-09-01), Adams et al.
patent: 4061656 (1977-12-01), Klaus et al.
patent: 4081476 (1978-03-01), Anderson et al.
patent: 4113858 (1978-09-01), Hashim
patent: 4116975 (1978-09-01), Klaus et al.
patent: 4127722 (1978-11-01), Lafon
patent: 4127723 (1978-11-01), Yankee
patent: 4130653 (1978-12-01), Giroux et al.
patent: 4171318 (1979-10-01), Chan et al.
patent: 4188338 (1980-02-01), Bruins et al.
patent: 4193931 (1980-03-01), Loeliger
patent: 4211783 (1980-07-01), Shepherd
patent: 4258057 (1981-03-01), Bartmann et al.
patent: 4288253 (1981-09-01), Venable
patent: 4309357 (1982-01-01), Chiusoli et al.
patent: 4309407 (1982-01-01), Lautenschlager et al.
patent: 4335054 (1982-06-01), Blaser et al.
patent: 4355168 (1982-10-01), Chiusoli et al.
patent: 4371614 (1983-02-01), Anderson et al.
patent: 4388459 (1983-06-01), Shepherd
patent: 4439443 (1984-03-01), Giroux
patent: 4440940 (1984-04-01), Shepherd
patent: 4472430 (1984-09-01), Loev et al.
patent: 4504494 (1985-03-01), Grollier et al.
patent: 4505930 (1985-03-01), Loev et al.
patent: 4534979 (1985-08-01), Loev et al.
patent: 4545984 (1985-10-01), Moller et al.
patent: 4564476 (1986-01-01), Ho
patent: 4604407 (1986-08-01), Haslanger et al.
patent: 4605669 (1986-08-01), Summers, Jr.
patent: 4607053 (1986-08-01), Karanewsky et al.
patent: 4608390 (1986-08-01), Summers, Jr.
patent: 4619945 (1986-10-01), Loev et al.
patent: 4621099 (1986-11-01), Loev et al.
patent: 4623661 (1986-11-01), Summers, Jr.
patent: 4638011 (1987-01-01), Das
patent: 4699920 (1987-10-01), Skuballa et al.
patent: 4709076 (1987-11-01), Bombardelli et al.
patent: 4722939 (1988-02-01), Loev et al.
patent: 4731382 (1988-03-01), Zusi et al.
patent: 4753934 (1988-06-01), Nickl et al.
patent: 4791133 (1988-12-01), Djuric et al.
patent: 4820828 (1989-04-01), Demers et al.
patent: 4833257 (1989-05-01), Pettit et al.
patent: 4950467 (1990-08-01), Phalangas et al.
patent: 4981865 (1991-01-01), Belliotti et al.
patent: 4985436 (1991-01-01), Pettit
patent: 5028629 (1991-07-01), Hite et al.
patent: 5064860 (1991-11-01), Mueller et al.
patent: 5075330 (1991-12-01), Belliotti et al.
patent: 5084214 (1992-01-01), Kita et al.
patent: 5089524 (1992-02-01), Collins et al.
patent: 5091569 (1992-02-01), Matsumoto et al.
patent: 5112846 (1992-05-01), Belliotti et al.
patent: 5141959 (1992-08-01), Carroll et al.
patent: 5235068 (1993-08-01), Minai et al.
patent: 5244922 (1993-09-01), Burzynski
patent: 5246955 (1993-09-01), Skibo et al.
patent: 5264424 (1993-11-01), Della Valle et al.
patent: 5272180 (1993-12-01), Hashimoto et al.
patent: 5320833 (1994-06-01), Deckers et al.
patent: 5369108 (1994-11-01), Breslow et al.
patent: 5385942 (1995-01-01), Abe et al.
patent: 5420160 (1995-05-01), Gayer et al.
patent: 5466718 (1995-11-01), Nakatsu et al.
patent: 5475022 (1995-12-01), Chandraratna
patent: 5486540 (1996-01-01), Andrews
patent: 5525629 (1996-06-01), Crimmin et al.
patent: 5541155 (1996-07-01), Leone-Bay et al.
patent: 5547988 (1996-08-01), Yu et al.
patent: 5602135 (1997-02-01), Chandraratna
patent: 5607978 (1997-03-01), Woodward et al.
patent: 5643949 (1997-07-01), Van Scott et al.
patent: 5672746 (1997-09-01), Nau et al.
patent: 5677320 (1997-10-01), Chandraratna
patent: 5688819 (1997-11-01), Woodward et al.
patent: 5696162 (1997-12-01), Chandraratna
patent: 5705167 (1998-01-01), Bernardon et al.
patent: 5710178 (1998-01-01), Samid
patent: 5753704 (1998-05-01), Lindner et al.
patent: 5795914 (1998-08-01), Konno et al.
patent: 5804601 (1998-09-01), Kato et al.
patent: 5883124 (1999-03-01), Samid
patent: 5891737 (1999-04-01), Baindur et al.
patent: 5908868 (1999-06-01), Buck et al.
patent: 5910508 (1999-06-01), Thoreau et al.
patent: 5910606 (1999-06-01), Foricher et al.
patent: 5932606 (1999-08-01), Isaacs et al.
patent: 5968979 (1999-10-01), Brusilow
patent: 5986131 (1999-11-01), Klaus et al.
patent: 5998654 (1999-12-01), Boehm et al.
patent: 6001877 (1999-12-01), Konno et al.
patent: 6004988 (1999-12-01), Amberg et al.
patent: 6030993 (2000-02-01), Jew et al.
patent: 6037367 (2000-03-01), Christensen, IV et al.
patent: 6043389 (2000-03-01), Nudelman et al.
patent: 6046237 (2000-04-01), Berge et al.
patent: 6060510 (2000-05-01), Brusilow
patent: 6068987 (2000-05-01), Dulski et al.
patent: 6071923 (2000-06-01), Nudelman et al.
patent: 6083984 (2000-07-01), Brusilow
patent: 6110697 (2000-08-01), Dulski et al.
patent: 6110955 (2000-08-01), Nudelman et al.
patent: 6110970 (2000-08-01), Nudelman et al.
patent: 6124495 (2000-09-01), Neiss et al.
patent: 6147224 (2000-11-01), Vuligonda et al.
patent: 6495719 (2002-12-01), Lan-Hargest et al.
patent: 2003/0195257 (2003-10-01), Fanto et al.
patent: 0 161 939 (1985-11-01), None
patent: 0 199 151 (1986-10-01), None
patent: WO 01/18171 (2001-03-01), None
patent: WO 01/38322 (2001-05-01), None
patent: WO 02/076941 (2002-10-01), None
patent: WO 03/013493 (2003-02-01), None
Summers et al, Journal of Medicinal Chemistry, Hydroxamic Acid Inhibitors of 5-Lipoxygenase: Quantitative Structure-Activity Relationships, 1990, 33, pp. 992-998.
Egan et al, American Journal of Resplratory Cell and Molecular Biology, Modulation of Ion Transport in cultured Rabbit Tracheal Epithelium by Lipoxygenase, 1993, Metabolites, 795, pp. 500-506.
Andrews et al., “Anti-malarial effect of histone deacetylation inhibitors and mammalian tumour cytodifferentiating agents,” International Journal for Parasitology, 30, pp. 761-768, (2000).
Collins, et al., “Oral Sodium Phenylbutyrate Therapy in Homozygous β Thalassemia: A Clinical Trial,” Blood, vol. 85, No. 1, pp. 43-49 (1995).
Finnin et al., “Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors,” Nature, vol. 41, pp. 188-193 (1999).
Fruehauf et al., “In Vitro Determination of Drug Response: A Discussion of Clinical Applications,” Principles & Practice of Oncology, vol. 7, No. 12, pp. 1-16, (1993).
Gore et al., “Modifying histones to tame cancer: clinical development of sodium phrnylbutyrate and other histone deacetylase inhibitors”, Exp. Opin. Invest. Drugs, 9(12), pp. 2923-2934, (2000).
Hoffman et al., “A non-isotopic assay for histone deacetylase activity,” Nucleic Acids Research, vol. 27, No. 9, pp. 2057-2058 (1999).
Kemp et al., “Gene redundancy and pharmacological gene therapy: Implications for X-linked adrenoleukodystrophy,” Nature Medicine, vol. 4, No. 11, pp. 1261-1268 (1998).
Kim et al., “Oxamflation is a novel antitumor compound that inhibits mammalian histone deacetylase,” Oncogene, vol. 18, pp. 2461-2470 (1999).
Marks et al., “Histone Deacetylase Inhibitors: Inducers of Differentiation or Apoptosis of Transformed Cell,” Journal of the National Cancer Institutie, vol. 92, No. 15, pp. 1210-1216 (2000).
Remiszewski et al., “Synthesis and in Vitro SAR of Straight Chain Hydroxamate Histone Deacetylase Inhibitors,” Proceedings of the AACR, vol. 42, No. 4976 (Feb. 27, 2001).
Rubenstein et al., “In Vitro Pharmacologic Restoration of CFTR-mediated Chloride Transport with Sodium 4-Phenylbutyrate in Cystic Fibrosis Epithelial Cells Containing ΔF5O8

Affiliated with

Also associated with

Rating

Treatment of lung cells with histone deacetylase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of lung cells with histone deacetylase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of lung cells with histone deacetylase inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3962981